These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15250378)

  • 1. [Bioartificial kidneys].
    Saito A
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():610-8. PubMed ID: 15250378
    [No Abstract]   [Full Text] [Related]  

  • 2. Research into the development of a wearable bioartificial kidney with a continuous hemofilter and a bioartificial tubule device using tubular epithelial cells.
    Saito A
    Artif Organs; 2004 Jan; 28(1):58-63. PubMed ID: 14720290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present status and perspective of the development of a bioartificial kidney for chronic renal failure patients.
    Saito A; Aung T; Sekiguchi K; Sato Y
    Ther Apher Dial; 2006 Aug; 10(4):342-7. PubMed ID: 16911187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells.
    Humes HD; Fissell WH; Weitzel WF; Buffington DA; Westover AJ; MacKay SM; Gutierrez JM
    Am J Kidney Dis; 2002 May; 39(5):1078-87. PubMed ID: 11979353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of cytokine response and survival time by bioartificial kidney therapy in acute uremic pigs with multi-organ dysfunction.
    Wang H; Zhang M; Wang X; Mao H; Ying X; Zhu W; Sun C; Jiang C
    Int J Artif Organs; 2010 Aug; 33(8):526-34. PubMed ID: 20872347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of bioartificial kidneys.
    Saito A
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S10-5. PubMed ID: 15012685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The portable hemofiltration-system].
    Saito A
    Nihon Rinsho; 2004 May; 62 Suppl 5():263-8. PubMed ID: 15197927
    [No Abstract]   [Full Text] [Related]  

  • 8. The bioartificial kidney and bioengineered membranes in acute kidney injury.
    Ding F; Humes HD
    Nephron Exp Nephrol; 2008; 109(4):e118-22. PubMed ID: 18802374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of renal support: high-flux dialysis to bioartificial kidneys.
    Tiranathanagul K; Eiam-Ong S; Humes HD
    Crit Care Clin; 2005 Apr; 21(2):379-94. PubMed ID: 15781170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High permeability dialysis membrane allows effective removal of myoglobin in acute kidney injury resulting from rhabdomyolysis.
    Sorrentino SA; Kielstein JT; Lukasz A; Sorrentino JN; Gohrbandt B; Haller H; Schmidt BM
    Crit Care Med; 2011 Jan; 39(1):184-6. PubMed ID: 21057310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of water and electrolyte transport of tubular epithelial cells under osmotic and hydraulic pressure for development of bioartificial tubules.
    Terashima M; Fujita Y; Sugano K; Asano M; Kagiwada N; Sheng Y; Nakamura S; Hasegawa A; Kakuta T; Saito A
    Artif Organs; 2001 Mar; 25(3):209-12. PubMed ID: 11284888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioartificial kidney: progress towards an ultrafiltration device with renal epithelial cells processing.
    Aebischer P; Ip TK; Panol G; Galletti PM
    Life Support Syst; 1987; 5(2):159-68. PubMed ID: 3669723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of long-term transport ability of a bioartificial renal tubule device using LLC-PK1 cells.
    Ozgen N; Terashima M; Aung T; Sato Y; Isoe C; Kakuta T; Saito A
    Nephrol Dial Transplant; 2004 Sep; 19(9):2198-207. PubMed ID: 15266032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present status and future perspectives on the development of bioartificial kidneys for the treatment of acute and chronic renal failure patients.
    Saito A; Sawada K; Fujimura S
    Hemodial Int; 2011 Apr; 15(2):183-92. PubMed ID: 21395969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous bioartificial kidney therapy on porcine multiple organ dysfunction syndrome with acute renal failure.
    Huijuan M; Xiaoyun W; Xumin Y; Hengjin W; Xia S
    ASAIO J; 2007; 53(3):329-34. PubMed ID: 17515724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
    Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
    Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of renal function in uremic animals with a tissue-engineered kidney.
    Humes HD; Buffington DA; MacKay SM; Funke AJ; Weitzel WF
    Nat Biotechnol; 1999 May; 17(5):451-5. PubMed ID: 10331803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure.
    Humes HD; Weitzel WF; Bartlett RH; Swaniker FC; Paganini EP
    Blood Purif; 2003; 21(1):64-71. PubMed ID: 12566664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underdosing continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury.
    Ricci Z; Romagnoli S
    J Crit Care; 2011 Apr; 26(2):221; author reply 222. PubMed ID: 21376525
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of tissue engineering in bioartificial renal tubule].
    Zhang Y; Zhang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jan; 19(1):144-7. PubMed ID: 11951504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.